← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
51	51 Solid Biosciences SLDB $615M	77	-5	-6%	$83.2M
52	AKUS 52 DELISTED Akouos Inc AKUS	74	-2	-3%	$165M
53	53 Taysha Gene Therapies TSHA $1.22B	71	+6	+9%	$111M
54	54 Voyager Therapeutics VYGR $127M	70	+11	+19%	$171M
55	55 Autolus Therapeutics AUTL $458M	67	-6	-8%	$229M
56	56 DELISTED Poseida Therapeutics, Inc. Common Stock PSTX	64	-2	-3%	$108M
57	57 Cabaletta Bio CABA $263M	62	-4	-6%	$36.9M
58	ORTX 58 DELISTED Orchard Therapeutics plc American Depositary Shares ORTX	62	-10	-14%	$39.8M
59	GMDA 59 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	59	-4	-6%	$84M
60	60 Abeona Therapeutics ABEO $266M	54	+2	+4%	$10.5M
61	AGTC 61 DELISTED Applied Genetic Technologies Corporation AGTC	53	-2	-4%	$16.2M
62	SQZ 62 DELISTED SQZ Biotechnologies Company SQZ	53	+3	+6%	$76.6M
63	63 Century Therapeutics IPSC $272M	52	+2	+4%	$279M
64	64 Cellectis CLLS $111M	50	-6	-11%	$55.8M
65	65 Tenaya Therapeutics TNYA $91.6M	50	+3	+6%	$440M
66	66 DELISTED Arcellx ACLX	49	+49	–	$358M
67	67 Eterna Therapeutics ERNA $2.53M	49	+2	+4%	$38.4M
68	68 Marker Therapeutics MRKR $15.3M	49	-15	-23%	$10.3M
69	SGTX 69 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	48	-2	-4%	$26.8M
70	70 Immatics IMTX $1.09B	47	-2	-4%	$173M
71	71 DELISTED CERo Therapeutics CERO	46	+10	+28%	$139M
72	LOGC 72 DELISTED LogicBio Therapeutics, Inc. Common Stock LOGC	46	-11	-19%	$8.66M
73	73 Senti Biosciences Holdings SNTI $8.14M	46	+4	+10%	$181M
74	74 DELISTED NKGen Biotech, Inc. Common Stock NKGN	44	+3	+7%	$120M
75	PTE 75 DELISTED PolarityTE, Inc. Common Stock PTE	44	+5	+13%	$4.07M